We are live on ! Find out more
OM icon

Outset Medical

61 hedge funds and large institutions have $163M invested in Outset Medical in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

599% more capital invested

Capital invested by funds: $23.4M → $163M (+$140M)

80.56% more ownership

Funds ownership: 2.67%83.23% (+81%)

0% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 19

12% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $2.67M

16% less funds holding

Funds holding: 7361 (-12)

40% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 30

Holders
61
Holders Change
-12
Holders Change %
-16.44%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
19
Reduced
19
Closed
30
Calls
$2.35M
Puts
$2.67M
Net Calls
-$323K
Net Calls Change
-$409K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$28.7M +$28M +2,352,113 +961%
DCP
2
Durable Capital Partners
Maryland
$19.2M +$20.7M +1,740,216 New
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$18.8M +$20.3M +1,703,083 New
PHS
4
PFM Health Sciences
California
$18.6M +$20.1M +1,685,727 New
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$17.7M +$19.1M +1,603,056 New
WP
6
Woodline Partners
California
$14.7M +$15.8M +1,325,784 New
Massachusetts Financial Services
7
Massachusetts Financial Services
Massachusetts
$9.29M +$10M +840,248 New
PA
8
Perceptive Advisors
New York
$9.22M +$9.94M +833,333 New
Marshall Wace
9
Marshall Wace
United Kingdom
$7.19M +$7.75M +650,264 New
PHP
10
Parkman Healthcare Partners
Connecticut
$2.56M +$2.76M +231,099 New
SSA
11
Schonfeld Strategic Advisors
New York
$2.1M +$2.27M +190,156 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.92M -$7.18K -602 -0.3%
CCM
13
Catalio Capital Management
New York
$1.84M +$1.99M +166,666 New
Millennium Management
14
Millennium Management
New York
$1.27M +$264K +22,178 +24%
GC
15
GMT Capital
Georgia
$1.09M -$72 -6 -0%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$985K +$265K +22,200 +33%
Ensign Peak Advisors
17
Ensign Peak Advisors
Utah
$934K -$19.3K -1,620 -2%
PVI
18
Pura Vida Investments
New York
$783K +$59.6K +5,000 New
CWG
19
C WorldWide Group
Denmark
$737K -$12 -1 -0%
BlackRock
20
BlackRock
New York
$729K +$40.1K +3,361 +5%
Morgan Stanley
21
Morgan Stanley
New York
$716K -$370K -31,057 -32%
TD Asset Management
22
TD Asset Management
Ontario, Canada
$589K +$635K +53,267 New
Renaissance Technologies
23
Renaissance Technologies
New York
$456K -$54.6K -4,577 -10%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$436K +$21.1K +1,772 +5%
Jane Street
25
Jane Street
New York
$375K +$318K +26,640 +366%

OM Hedge Fund Activity: Q1 2025 in Review

61 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2025, worth a combined $163M — up 599% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of OM and 18 opened new positions — a net loss of 12 holders — while 19 trimmed existing stakes and 19 added.

The largest buyer was Fidelity Investments, adding an estimated $28M. The largest seller was Deutsche Bank, exiting entirely with an estimated $463K sold.

  • 61 institutional investors held Outset Medical (OM) as of Q1 2025, down from 73 in Q4 2024.
  • Funds reported $163M of Outset Medical stock for Q1 2025, up 599% quarter-over-quarter.
  • 18 funds opened new Outset Medical positions in Q1 2025 and 30 closed out, a net change of -12 holders.
  • The largest Outset Medical buyer in Q1 2025 was Fidelity Investments, an estimated $28M added.
  • The largest Outset Medical seller in Q1 2025 was Deutsche Bank, an estimated $463K sold.

Based on aggregated 13F filings for Q1 2025.